Breaking down of the healthcare system: Mathematical modelling for controlling the novel coronavirus (2019-nCoV) outbreak in Wuhan, China

A novel coronavirus pneumonia initially identified in Wuhan, China and provisionally named 2019-nCoV has surged in the public. In anticipation of substantial burdens on healthcare system following this human-to-human spread, we aim to scrutinise the currently available information and evaluate the burden of healthcare systems during this outbreak in Wuhan. We applied a modified SIR model to project the actual number of infected cases and the specific burdens on isolation wards and intensive care units, given the scenarios of different diagnosis rates as well as different public health intervention efficacy. Our estimates suggest the actual number of infected cases could be much higher than the reported, with estimated 26,701 cases (as of 28th January 2020) assuming 50% diagnosis rate if no public health interventions were implemented. The estimated burdens on healthcare system could be largely reduced if at least 70% efficacy of public health intervention is achieved.

[1]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[2]  Tao Liu,et al.  Time-varying transmission dynamics of Novel Coronavirus Pneumonia in China , 2020, medRxiv.

[3]  D. Cummings,et al.  Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions , 2020, medRxiv.

[4]  Jianhong Wu,et al.  Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions , 2020, Journal of clinical medicine.

[5]  D. Cummings,et al.  Strategies for mitigating an influenza pandemic , 2006, Nature.

[6]  Jianhong Wu,et al.  Estimation of the Transmission Risk of the 2019-nCoV and Its Implication for Public Health Interventions , 2020, Journal of clinical medicine.

[7]  Benjamin J Cowling,et al.  Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[8]  J. Parry,et al.  China coronavirus: cases surge as official admits human to human transmission , 2020, BMJ.

[9]  Wenjun Ma,et al.  Transmission Dynamics of 2019 Novel Coronavirus (2019-nCoV) , 2020 .

[10]  M. Cetron,et al.  School Closure to Reduce Influenza Transmission , 2009, Emerging infectious diseases.

[11]  M. Baguelin,et al.  Report 3: Transmissibility of 2019-nCoV , 2020 .

[12]  Wenjun Ma,et al.  Transmission dynamics of 2019 novel coronavirus (2019-nCoV) , 2020, bioRxiv.

[13]  Zhihang Peng,et al.  Modeling the Epidemic Trend of the 2019 Novel Coronavirus Outbreak in China , 2020, bioRxiv.

[14]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[15]  L. Yang,et al.  Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak , 2020, bioRxiv.

[16]  B J Cowling,et al.  Effectiveness of control measures during the SARS epidemic in Beijing: a comparison of the Rt curve and the epidemic curve , 2007, Epidemiology and Infection.

[17]  Christl A. Donnelly,et al.  Report 2: Estimating the potential total number of novel Coronavirus cases in Wuhan City, China , 2020 .

[18]  Alexandria C Brown,et al.  N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial. , 2019, JAMA.